MedPath

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma

Phase 3
Conditions
Lymphoma
Registration Number
NCT00006250
Lead Sponsor
Lymphoma Trials Office
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective for non-Hodgkin's lymphoma.

PURPOSE: Randomized phase III trial to compare the effectiveness of two different combination chemotherapy regimens in treating patients who have stage III or stage IV non-Hodgkin's lymphoma.

Detailed Description

OBJECTIVES:

* Compare the overall survival rate, progression free survival rate, clinical and molecular remission rates, and time to treatment failure in patients with newly diagnosed stage III or IV follicular non-Hodgkin's lymphoma treated with chlorambucil, mitoxantrone, and dexamethasone versus fludarabine, mitoxantrone, and dexamethasone.

* Compare the efficacy and tolerability of these regimens in these patients.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to International Prognostic Index score \[low risk (score 1) vs intermediate low risk (score 2) vs intermediate high risk (score 3) vs high risk (score 4 or 5)\]. Patients are randomized to one of two treatment arms.

* Arm I: Patients receive mitoxantrone IV on day 1, oral chlorambucil on days 1-10, and oral dexamethasone on days 1-5.

* Arm II: Patients receive mitoxantrone and dexamethasone as in arm I and fludarabine IV on days 1-3.

Treatment continues every 4 weeks for 4-8 courses.

Patients are followed at 3, 6, and 12 months, every 6 months for 1 year, and then annually thereafter until clinical relapse.

PROJECTED ACCRUAL: A total of 500 patients (250 per arm) will be accrued for this study within 4 years.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to treatment failure
Progression-free survival rate
Overall survival rate
Secondary Outcome Measures
NameTimeMethod
Clinical remission rate
Molecular remission rate

Trial Locations

Locations (59)

St. Thomas' Hospital

🇬🇧

London, England, United Kingdom

Birmingham Heartlands Hospital

🇬🇧

Birmingham, England, United Kingdom

Craigavon Area Hospital

🇬🇧

Craigavon, Northern Ireland, United Kingdom

Velindre Cancer Center at Velindre Hospital

🇬🇧

Cardiff, Wales, United Kingdom

Pembury Hospital

🇬🇧

Royal Tunbridge Wells, Kent, England, United Kingdom

Scunthorpe General Hospital

🇬🇧

Scunthorpe, England, United Kingdom

Derbyshire Royal Infirmary

🇬🇧

Derby, England, United Kingdom

Yeovil District Hospital

🇬🇧

Yeovil - Somerset, England, United Kingdom

Centre for Cancer Research and Cell Biology at Belfast City Hospital

🇬🇧

Belfast, Northern Ireland, United Kingdom

Glan Clywd District General Hospital

🇬🇧

Rhyl, Denbighshire, Wales, United Kingdom

Mount Vernon Cancer Centre at Mount Vernon Hospital

🇬🇧

Northwood, England, United Kingdom

University College of London Hospitals

🇬🇧

London, England, United Kingdom

Taunton and Somerset Hospital

🇬🇧

Taunton Somerset, England, United Kingdom

University Hospital of Wales

🇬🇧

Cardiff, Wales, United Kingdom

Epsom General Hospital

🇬🇧

Epsom Surrey, England, United Kingdom

Wycombe General Hospital

🇬🇧

High Wycombe, England, United Kingdom

St Helier Hospital

🇬🇧

Carshalton, England, United Kingdom

Kettering General Hosptial

🇬🇧

Kettering, Northants, England, United Kingdom

Queen Elizabeth Hospital

🇬🇧

King's Lynn, England, United Kingdom

Basildon University Hospital

🇬🇧

Basildon, England, United Kingdom

Dartford & Gravesham NHS Trust, Joyce Green Hospital

🇬🇧

Dartford Kent, England, United Kingdom

Ipswich Hospital NHS Trust

🇬🇧

Ipswich, England, United Kingdom

Hillingdon Hospital

🇬🇧

Uxbridge, England, United Kingdom

Sandwell General Hospital

🇬🇧

West Bromwich, England, United Kingdom

St. Georges, University of London

🇬🇧

London, England, United Kingdom

Saint Richards Hospital

🇬🇧

Chichester, England, United Kingdom

Russells Hall Hospital

🇬🇧

Dudley, England, United Kingdom

West Middlesex University Hospital

🇬🇧

Isleworth, England, United Kingdom

Royal Hallamshire Hospital

🇬🇧

Sheffield, England, United Kingdom

Stoke Mandeville Hospital

🇬🇧

Aylesbury-Buckinghamshire, England, United Kingdom

Leicester Royal Infirmary

🇬🇧

Leicester, England, United Kingdom

Derriford Hospital

🇬🇧

Plymouth, England, United Kingdom

Ulster Hospital

🇬🇧

Dundonald, Northern Ireland, United Kingdom

Hull Royal Infirmary

🇬🇧

Hull, England, United Kingdom

Kent and Canterbury Hospital

🇬🇧

Canterbury, England, United Kingdom

Walsgrave Hospital

🇬🇧

Coventry, England, United Kingdom

Doncaster Royal Infirmary

🇬🇧

Doncaster, England, United Kingdom

Good Hope Hospital Trust

🇬🇧

West Midlands, England, United Kingdom

Rotherham District General Hospital - NHS Trust

🇬🇧

Rotherham, England, United Kingdom

Pinderfields Hospital NHS Trust

🇬🇧

Wakefield, Scotland, United Kingdom

Northwick Park Hospital

🇬🇧

Harrow, England, United Kingdom

Huddersfield Royal Infirmary

🇬🇧

Huddersfield, West Yorks, England, United Kingdom

Aintree University Hospital

🇬🇧

Liverpool, England, United Kingdom

Staffordshire General Hospital

🇬🇧

Stafford, England, United Kingdom

Great Ormond Street Hospital for Children NHS Trust

🇬🇧

London, England, United Kingdom

Bradford Hospitals NHS Trust

🇬🇧

Bradford, England, United Kingdom

Clinical Trials and Research Unit of the University of Leeds

🇬🇧

Leeds, England, United Kingdom

Leeds Cancer Centre at St. James's University Hospital

🇬🇧

Leeds, England, United Kingdom

Nottingham City Hospital NHS Trust

🇬🇧

Nottingham, England, United Kingdom

Pontefract General Infirmary

🇬🇧

Pontefract West Yorkshire, England, United Kingdom

Oldchurch Hospital

🇬🇧

Romford, England, United Kingdom

Cancer Research Centre at Weston Park Hospital

🇬🇧

Sheffield, England, United Kingdom

Royal Marsden NHS Foundation Trust - Surrey

🇬🇧

Sutton, England, United Kingdom

Torbay Hospital

🇬🇧

Torquay Devon, England, United Kingdom

New Cross Hospital

🇬🇧

Wolverhampton, England, United Kingdom

Worthing Hospital

🇬🇧

Worthing, England, United Kingdom

Cancer Care Centre at York Hospital

🇬🇧

York, England, United Kingdom

Ysbyty Gwynedd

🇬🇧

Bangor, Wales, United Kingdom

Singleton Hospital of the Swansea NHS Trust

🇬🇧

Swansea, Wales, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath